| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2726225 | The American Journal of Medicine | 2006 | 7 Pages |
Abstract
These findings suggest that, in patients with moderate to severe chronic kidney disease, safety concerns about adverse outcomes and the absence of trial data for this population may limit the use of guidelines-recommended therapies and interventions for non-ST-segment elevation acute coronary syndromes. The decreased use of discharge counseling in patients with moderate to severe chronic kidney disease and non-ST-segment elevation acute coronary syndromes may represent therapeutic nihilism.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jin H. MD, Abhinav MD, Jyotsna MS, Matthew T. MD, MHS, Eric D. MD, MPH, Lynda A. MD, Uptal MD, E. Magnus MD, Christopher J. PhD, W. Brian MD,